Celladon

Celladon Corporation is a biotechnology company that develops and produces molecular therapies for the treatment of heart failure. Its products include SERCA2a, an enzyme that regulates calcium cycling and contractility in cardiac muscle cells, and MYDICAR, an enzyme replacement therapy for heart failure.